Loading…
Potentially Inappropriate Use of Psychotropic Medications in Hospitalized Elderly Patients in France: Cross-Sectional Analysis of the Prospective, Multicentre SAFEs Cohort
Background: In France, there is evidence to suggest that 50% of elderly individuals are prescribed psychotropic medications. However, it is known that use of these agents increases the risk of falls, fractures and delirium in older people. Objective: To study the consumption of ‘potentially inapprop...
Saved in:
Published in: | Drugs & aging 2008-01, Vol.25 (11), p.933-946 |
---|---|
Main Authors: | , , , , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | |
---|---|
cites | cdi_FETCH-LOGICAL-c430t-9c4e373a2fe6e40a11d4fe9d6c73e5b258872f1c2937fa267669ccd2ad2a079a3 |
container_end_page | 946 |
container_issue | 11 |
container_start_page | 933 |
container_title | Drugs & aging |
container_volume | 25 |
creator | Prudent, Max Dramé, Moustapha Jolly, Damien Trenque, Thierry Parjoie, Renaud Mahmoudi, Rachid Lang, Pierre-Olivier Somme, Dominique Boyer, François Lanièce, Isabelle Gauvain, Jean-Bernard Blanchard, François Novella, Jean-Luc |
description | Background:
In France, there is evidence to suggest that 50% of elderly individuals are prescribed psychotropic medications. However, it is known that use of these agents increases the risk of falls, fractures and delirium in older people.
Objective:
To study the consumption of ‘potentially inappropriate medication’ (PIM) among patients aged ≥75 years, paying particular attention to psychotropic drugs and the factors influencing the use of ‘potentially inappropriate psychotropics’ (PIPs).
Method:
This was a cross-sectional analysis of a prospective multicentre cohort of 1306 hospitalized French patients aged ≥75 years (the SAFEs [Sujet Âgé Fragile: Évaluation et suivi (Frail Elderly Subjects: Evaluation and follow-up)] cohort). The present analysis involved the 1176 patients for whom there was information on the usual treatments being taken in the 2 weeks before hospitalization. The drugs were coded according to the Anatomical Therapeutic Chemical classification; the Beers list as updated in 2003 defined which medications were considered PIPs. Standardized geriatric assessment variables were recorded on inclusion in the study. Logistic regression analysis was performed to identify factors linked to use of psychotropics and PIPs.
Results:
The mean number of drugs taken was 5.7 ± 2.9 per patient. Twenty-eight percent of patients took at least one PIM. The number of patients who had taken at least one psychotropic drug in the 2 weeks before hospitalization (mean 1.6 ± 0.9 psychotropics per patient) was 589 (50.1%). More than half of both the 510 patients with a depressive syndrome and the 543 patients affected by dementia were treated with psychotropics. Multivariate analysis showed that prescription of psychotropics was linked to the presence of a dementia syndrome (odds ratio [OR] = 1.4; 95% CI 1.1, 1.9; p = 0.03), the presence of a depressive syndrome (OR = 1.7; 95% CI 1.3, 2.1; p < 0.001), living in an institution (OR = 2.2; 95% CI 1.5, 3.4; p < 0.001), use of more than five drugs (OR = 3.2; 95% CI 2.5, 4.2; p < 0.001) and Charlson’s co-morbidity score >1 (OR = 0.6; 95% CI 0.5, 0.8; p = 0.001). Nineteen percent of all psychotropics prescribed were PIPs. Of these PIPs, 66.5% were anxiolytics, 28.4% were antidepressants and 5.1% were antipsychotics. Use of PIPs in the multivariate analysis was associated only with consumption of more than five drugs (OR = 1.7; 95% CI 1.1, 2.5; p = 0.01).
Conclusion:
PIM use is common among hospitalized older adults in Franc |
doi_str_mv | 10.2165/0002512-200825110-00004 |
format | article |
fullrecord | <record><control><sourceid>gale_proqu</sourceid><recordid>TN_cdi_proquest_journals_223084924</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A200671326</galeid><sourcerecordid>A200671326</sourcerecordid><originalsourceid>FETCH-LOGICAL-c430t-9c4e373a2fe6e40a11d4fe9d6c73e5b258872f1c2937fa267669ccd2ad2a079a3</originalsourceid><addsrcrecordid>eNqFkVFLHDEQx5dSqdb2K7RLSx9Xk9ndZPMoolVQvAeFvoWYTGxkL7kmew_np-94tyiFgiSQYeY3k5n5V9VXzo6Ai_6YMQY9hwYYG8jgrCEP695VB5xL1XAl1PutzRoA9Wu_-ljKIxECgH-o9vmgOgmCH1RukSaMUzDjuKkvo1mtclrlYCas7wrWydeLsrG_00TuYOtrdMGaKaRY6hDri1RWYTJjeEJXn40OM1VZUJxKboHzbKLFT9WeN2PBz_N7WN2dn92eXjRXNz8vT0-uGtu1bGqU7bCVrQGPAjtmOHedR-WElS3299APgwTPLahWegNCCqGsdWDoMqlMe1h929WlIf6ssUz6Ma1zpC81QMuGTkFH0Pcd9GBG1CF6ms3YZShWn9A6heQtCKKO_kPRcbgMNkX0gfz_JMhdgs2plIxe0xqXJm80Z_pZMz1rpl8001vNKPPL3PX6fonuNW8WiYAfM2CKNaN_3mkoLxywQbC-H4gbdlyhUHzA_Dr-Wz38BUV9rgM</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>223084924</pqid></control><display><type>article</type><title>Potentially Inappropriate Use of Psychotropic Medications in Hospitalized Elderly Patients in France: Cross-Sectional Analysis of the Prospective, Multicentre SAFEs Cohort</title><source>Springer Link</source><creator>Prudent, Max ; Dramé, Moustapha ; Jolly, Damien ; Trenque, Thierry ; Parjoie, Renaud ; Mahmoudi, Rachid ; Lang, Pierre-Olivier ; Somme, Dominique ; Boyer, François ; Lanièce, Isabelle ; Gauvain, Jean-Bernard ; Blanchard, François ; Novella, Jean-Luc</creator><creatorcontrib>Prudent, Max ; Dramé, Moustapha ; Jolly, Damien ; Trenque, Thierry ; Parjoie, Renaud ; Mahmoudi, Rachid ; Lang, Pierre-Olivier ; Somme, Dominique ; Boyer, François ; Lanièce, Isabelle ; Gauvain, Jean-Bernard ; Blanchard, François ; Novella, Jean-Luc</creatorcontrib><description>Background:
In France, there is evidence to suggest that 50% of elderly individuals are prescribed psychotropic medications. However, it is known that use of these agents increases the risk of falls, fractures and delirium in older people.
Objective:
To study the consumption of ‘potentially inappropriate medication’ (PIM) among patients aged ≥75 years, paying particular attention to psychotropic drugs and the factors influencing the use of ‘potentially inappropriate psychotropics’ (PIPs).
Method:
This was a cross-sectional analysis of a prospective multicentre cohort of 1306 hospitalized French patients aged ≥75 years (the SAFEs [Sujet Âgé Fragile: Évaluation et suivi (Frail Elderly Subjects: Evaluation and follow-up)] cohort). The present analysis involved the 1176 patients for whom there was information on the usual treatments being taken in the 2 weeks before hospitalization. The drugs were coded according to the Anatomical Therapeutic Chemical classification; the Beers list as updated in 2003 defined which medications were considered PIPs. Standardized geriatric assessment variables were recorded on inclusion in the study. Logistic regression analysis was performed to identify factors linked to use of psychotropics and PIPs.
Results:
The mean number of drugs taken was 5.7 ± 2.9 per patient. Twenty-eight percent of patients took at least one PIM. The number of patients who had taken at least one psychotropic drug in the 2 weeks before hospitalization (mean 1.6 ± 0.9 psychotropics per patient) was 589 (50.1%). More than half of both the 510 patients with a depressive syndrome and the 543 patients affected by dementia were treated with psychotropics. Multivariate analysis showed that prescription of psychotropics was linked to the presence of a dementia syndrome (odds ratio [OR] = 1.4; 95% CI 1.1, 1.9; p = 0.03), the presence of a depressive syndrome (OR = 1.7; 95% CI 1.3, 2.1; p < 0.001), living in an institution (OR = 2.2; 95% CI 1.5, 3.4; p < 0.001), use of more than five drugs (OR = 3.2; 95% CI 2.5, 4.2; p < 0.001) and Charlson’s co-morbidity score >1 (OR = 0.6; 95% CI 0.5, 0.8; p = 0.001). Nineteen percent of all psychotropics prescribed were PIPs. Of these PIPs, 66.5% were anxiolytics, 28.4% were antidepressants and 5.1% were antipsychotics. Use of PIPs in the multivariate analysis was associated only with consumption of more than five drugs (OR = 1.7; 95% CI 1.1, 2.5; p = 0.01).
Conclusion:
PIM use is common among hospitalized older adults in France. The most important determinant of risk of receiving a psychotropic medication or a PIP was the number of drugs being taken. The elderly, who have multiple comorbidities, complex chronic conditions and are usually receiving polypharmacy, are at increased risk for adverse drug events. These adverse events are often linked to problems that could be preventable such as delirium, depression and falls. Regular review of prescriptions would help optimize prescription of psychotropics in the elderly. The Beers list is a good tool for evaluating PIMs but is too restrictive with respect to psychotropics; in the latter respect, the list could usefully be widened.</description><identifier>ISSN: 1170-229X</identifier><identifier>EISSN: 1179-1969</identifier><identifier>DOI: 10.2165/0002512-200825110-00004</identifier><identifier>PMID: 18947261</identifier><language>eng</language><publisher>Cham: Springer International Publishing</publisher><subject>Activities of Daily Living ; Age Factors ; Aged - statistics & numerical data ; Aged patients ; Aged, 80 and over ; Biological and medical sciences ; Cross-Sectional Studies ; Data Collection ; Delirium ; Delirium - complications ; Delirium - psychology ; Dementia ; Dementia - complications ; Dementia - psychology ; Dosage and administration ; Drug Interactions ; Drug therapy ; Drug Utilization ; Emergency medical care ; Female ; Frail Elderly - statistics & numerical data ; Frailty ; France - epidemiology ; Geriatrics ; Geriatrics/Gerontology ; Health aspects ; Hospital patients ; Hospitalization ; Hospitals ; Humans ; Internal Medicine ; Logistic Models ; Male ; Medical sciences ; Medicine ; Medicine & Public Health ; Multivariate analysis ; Neuropharmacology ; Older people ; Original Research Article ; Patients ; Pharmacology. Drug treatments ; Pharmacology/Toxicology ; Pharmacotherapy ; Polypharmacy ; Prescription drugs ; Prescriptions - standards ; Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer ; Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer..., (alzheimer disease) ; Psychology. Psychoanalysis. Psychiatry ; Psychopharmacology ; Psychotropic drugs ; Psychotropic Drugs - therapeutic use ; Socioeconomic Factors</subject><ispartof>Drugs & aging, 2008-01, Vol.25 (11), p.933-946</ispartof><rights>Adis Data Information BV 2008</rights><rights>2009 INIST-CNRS</rights><rights>COPYRIGHT 2008 Wolters Kluwer Health, Inc.</rights><rights>Copyright Wolters Kluwer Health Adis International 2008</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c430t-9c4e373a2fe6e40a11d4fe9d6c73e5b258872f1c2937fa267669ccd2ad2a079a3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,777,781,27905,27906</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=20860558$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/18947261$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Prudent, Max</creatorcontrib><creatorcontrib>Dramé, Moustapha</creatorcontrib><creatorcontrib>Jolly, Damien</creatorcontrib><creatorcontrib>Trenque, Thierry</creatorcontrib><creatorcontrib>Parjoie, Renaud</creatorcontrib><creatorcontrib>Mahmoudi, Rachid</creatorcontrib><creatorcontrib>Lang, Pierre-Olivier</creatorcontrib><creatorcontrib>Somme, Dominique</creatorcontrib><creatorcontrib>Boyer, François</creatorcontrib><creatorcontrib>Lanièce, Isabelle</creatorcontrib><creatorcontrib>Gauvain, Jean-Bernard</creatorcontrib><creatorcontrib>Blanchard, François</creatorcontrib><creatorcontrib>Novella, Jean-Luc</creatorcontrib><title>Potentially Inappropriate Use of Psychotropic Medications in Hospitalized Elderly Patients in France: Cross-Sectional Analysis of the Prospective, Multicentre SAFEs Cohort</title><title>Drugs & aging</title><addtitle>Drugs Aging</addtitle><addtitle>Drugs Aging</addtitle><description>Background:
In France, there is evidence to suggest that 50% of elderly individuals are prescribed psychotropic medications. However, it is known that use of these agents increases the risk of falls, fractures and delirium in older people.
Objective:
To study the consumption of ‘potentially inappropriate medication’ (PIM) among patients aged ≥75 years, paying particular attention to psychotropic drugs and the factors influencing the use of ‘potentially inappropriate psychotropics’ (PIPs).
Method:
This was a cross-sectional analysis of a prospective multicentre cohort of 1306 hospitalized French patients aged ≥75 years (the SAFEs [Sujet Âgé Fragile: Évaluation et suivi (Frail Elderly Subjects: Evaluation and follow-up)] cohort). The present analysis involved the 1176 patients for whom there was information on the usual treatments being taken in the 2 weeks before hospitalization. The drugs were coded according to the Anatomical Therapeutic Chemical classification; the Beers list as updated in 2003 defined which medications were considered PIPs. Standardized geriatric assessment variables were recorded on inclusion in the study. Logistic regression analysis was performed to identify factors linked to use of psychotropics and PIPs.
Results:
The mean number of drugs taken was 5.7 ± 2.9 per patient. Twenty-eight percent of patients took at least one PIM. The number of patients who had taken at least one psychotropic drug in the 2 weeks before hospitalization (mean 1.6 ± 0.9 psychotropics per patient) was 589 (50.1%). More than half of both the 510 patients with a depressive syndrome and the 543 patients affected by dementia were treated with psychotropics. Multivariate analysis showed that prescription of psychotropics was linked to the presence of a dementia syndrome (odds ratio [OR] = 1.4; 95% CI 1.1, 1.9; p = 0.03), the presence of a depressive syndrome (OR = 1.7; 95% CI 1.3, 2.1; p < 0.001), living in an institution (OR = 2.2; 95% CI 1.5, 3.4; p < 0.001), use of more than five drugs (OR = 3.2; 95% CI 2.5, 4.2; p < 0.001) and Charlson’s co-morbidity score >1 (OR = 0.6; 95% CI 0.5, 0.8; p = 0.001). Nineteen percent of all psychotropics prescribed were PIPs. Of these PIPs, 66.5% were anxiolytics, 28.4% were antidepressants and 5.1% were antipsychotics. Use of PIPs in the multivariate analysis was associated only with consumption of more than five drugs (OR = 1.7; 95% CI 1.1, 2.5; p = 0.01).
Conclusion:
PIM use is common among hospitalized older adults in France. The most important determinant of risk of receiving a psychotropic medication or a PIP was the number of drugs being taken. The elderly, who have multiple comorbidities, complex chronic conditions and are usually receiving polypharmacy, are at increased risk for adverse drug events. These adverse events are often linked to problems that could be preventable such as delirium, depression and falls. Regular review of prescriptions would help optimize prescription of psychotropics in the elderly. The Beers list is a good tool for evaluating PIMs but is too restrictive with respect to psychotropics; in the latter respect, the list could usefully be widened.</description><subject>Activities of Daily Living</subject><subject>Age Factors</subject><subject>Aged - statistics & numerical data</subject><subject>Aged patients</subject><subject>Aged, 80 and over</subject><subject>Biological and medical sciences</subject><subject>Cross-Sectional Studies</subject><subject>Data Collection</subject><subject>Delirium</subject><subject>Delirium - complications</subject><subject>Delirium - psychology</subject><subject>Dementia</subject><subject>Dementia - complications</subject><subject>Dementia - psychology</subject><subject>Dosage and administration</subject><subject>Drug Interactions</subject><subject>Drug therapy</subject><subject>Drug Utilization</subject><subject>Emergency medical care</subject><subject>Female</subject><subject>Frail Elderly - statistics & numerical data</subject><subject>Frailty</subject><subject>France - epidemiology</subject><subject>Geriatrics</subject><subject>Geriatrics/Gerontology</subject><subject>Health aspects</subject><subject>Hospital patients</subject><subject>Hospitalization</subject><subject>Hospitals</subject><subject>Humans</subject><subject>Internal Medicine</subject><subject>Logistic Models</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Medicine</subject><subject>Medicine & Public Health</subject><subject>Multivariate analysis</subject><subject>Neuropharmacology</subject><subject>Older people</subject><subject>Original Research Article</subject><subject>Patients</subject><subject>Pharmacology. Drug treatments</subject><subject>Pharmacology/Toxicology</subject><subject>Pharmacotherapy</subject><subject>Polypharmacy</subject><subject>Prescription drugs</subject><subject>Prescriptions - standards</subject><subject>Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer</subject><subject>Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer..., (alzheimer disease)</subject><subject>Psychology. Psychoanalysis. Psychiatry</subject><subject>Psychopharmacology</subject><subject>Psychotropic drugs</subject><subject>Psychotropic Drugs - therapeutic use</subject><subject>Socioeconomic Factors</subject><issn>1170-229X</issn><issn>1179-1969</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2008</creationdate><recordtype>article</recordtype><recordid>eNqFkVFLHDEQx5dSqdb2K7RLSx9Xk9ndZPMoolVQvAeFvoWYTGxkL7kmew_np-94tyiFgiSQYeY3k5n5V9VXzo6Ai_6YMQY9hwYYG8jgrCEP695VB5xL1XAl1PutzRoA9Wu_-ljKIxECgH-o9vmgOgmCH1RukSaMUzDjuKkvo1mtclrlYCas7wrWydeLsrG_00TuYOtrdMGaKaRY6hDri1RWYTJjeEJXn40OM1VZUJxKboHzbKLFT9WeN2PBz_N7WN2dn92eXjRXNz8vT0-uGtu1bGqU7bCVrQGPAjtmOHedR-WElS3299APgwTPLahWegNCCqGsdWDoMqlMe1h929WlIf6ssUz6Ma1zpC81QMuGTkFH0Pcd9GBG1CF6ms3YZShWn9A6heQtCKKO_kPRcbgMNkX0gfz_JMhdgs2plIxe0xqXJm80Z_pZMz1rpl8001vNKPPL3PX6fonuNW8WiYAfM2CKNaN_3mkoLxywQbC-H4gbdlyhUHzA_Dr-Wz38BUV9rgM</recordid><startdate>20080101</startdate><enddate>20080101</enddate><creator>Prudent, Max</creator><creator>Dramé, Moustapha</creator><creator>Jolly, Damien</creator><creator>Trenque, Thierry</creator><creator>Parjoie, Renaud</creator><creator>Mahmoudi, Rachid</creator><creator>Lang, Pierre-Olivier</creator><creator>Somme, Dominique</creator><creator>Boyer, François</creator><creator>Lanièce, Isabelle</creator><creator>Gauvain, Jean-Bernard</creator><creator>Blanchard, François</creator><creator>Novella, Jean-Luc</creator><general>Springer International Publishing</general><general>Adis International</general><general>Wolters Kluwer Health, Inc</general><general>Springer Nature B.V</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>4T-</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88G</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>M2M</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PSYQQ</scope><scope>Q9U</scope></search><sort><creationdate>20080101</creationdate><title>Potentially Inappropriate Use of Psychotropic Medications in Hospitalized Elderly Patients in France</title><author>Prudent, Max ; Dramé, Moustapha ; Jolly, Damien ; Trenque, Thierry ; Parjoie, Renaud ; Mahmoudi, Rachid ; Lang, Pierre-Olivier ; Somme, Dominique ; Boyer, François ; Lanièce, Isabelle ; Gauvain, Jean-Bernard ; Blanchard, François ; Novella, Jean-Luc</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c430t-9c4e373a2fe6e40a11d4fe9d6c73e5b258872f1c2937fa267669ccd2ad2a079a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2008</creationdate><topic>Activities of Daily Living</topic><topic>Age Factors</topic><topic>Aged - statistics & numerical data</topic><topic>Aged patients</topic><topic>Aged, 80 and over</topic><topic>Biological and medical sciences</topic><topic>Cross-Sectional Studies</topic><topic>Data Collection</topic><topic>Delirium</topic><topic>Delirium - complications</topic><topic>Delirium - psychology</topic><topic>Dementia</topic><topic>Dementia - complications</topic><topic>Dementia - psychology</topic><topic>Dosage and administration</topic><topic>Drug Interactions</topic><topic>Drug therapy</topic><topic>Drug Utilization</topic><topic>Emergency medical care</topic><topic>Female</topic><topic>Frail Elderly - statistics & numerical data</topic><topic>Frailty</topic><topic>France - epidemiology</topic><topic>Geriatrics</topic><topic>Geriatrics/Gerontology</topic><topic>Health aspects</topic><topic>Hospital patients</topic><topic>Hospitalization</topic><topic>Hospitals</topic><topic>Humans</topic><topic>Internal Medicine</topic><topic>Logistic Models</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Medicine</topic><topic>Medicine & Public Health</topic><topic>Multivariate analysis</topic><topic>Neuropharmacology</topic><topic>Older people</topic><topic>Original Research Article</topic><topic>Patients</topic><topic>Pharmacology. Drug treatments</topic><topic>Pharmacology/Toxicology</topic><topic>Pharmacotherapy</topic><topic>Polypharmacy</topic><topic>Prescription drugs</topic><topic>Prescriptions - standards</topic><topic>Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer</topic><topic>Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer..., (alzheimer disease)</topic><topic>Psychology. Psychoanalysis. Psychiatry</topic><topic>Psychopharmacology</topic><topic>Psychotropic drugs</topic><topic>Psychotropic Drugs - therapeutic use</topic><topic>Socioeconomic Factors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Prudent, Max</creatorcontrib><creatorcontrib>Dramé, Moustapha</creatorcontrib><creatorcontrib>Jolly, Damien</creatorcontrib><creatorcontrib>Trenque, Thierry</creatorcontrib><creatorcontrib>Parjoie, Renaud</creatorcontrib><creatorcontrib>Mahmoudi, Rachid</creatorcontrib><creatorcontrib>Lang, Pierre-Olivier</creatorcontrib><creatorcontrib>Somme, Dominique</creatorcontrib><creatorcontrib>Boyer, François</creatorcontrib><creatorcontrib>Lanièce, Isabelle</creatorcontrib><creatorcontrib>Gauvain, Jean-Bernard</creatorcontrib><creatorcontrib>Blanchard, François</creatorcontrib><creatorcontrib>Novella, Jean-Luc</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Docstoc</collection><collection>Nursing & Allied Health Database</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Psychology Database (Alumni)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Psychology Database</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest One Psychology</collection><collection>ProQuest Central Basic</collection><jtitle>Drugs & aging</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Prudent, Max</au><au>Dramé, Moustapha</au><au>Jolly, Damien</au><au>Trenque, Thierry</au><au>Parjoie, Renaud</au><au>Mahmoudi, Rachid</au><au>Lang, Pierre-Olivier</au><au>Somme, Dominique</au><au>Boyer, François</au><au>Lanièce, Isabelle</au><au>Gauvain, Jean-Bernard</au><au>Blanchard, François</au><au>Novella, Jean-Luc</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Potentially Inappropriate Use of Psychotropic Medications in Hospitalized Elderly Patients in France: Cross-Sectional Analysis of the Prospective, Multicentre SAFEs Cohort</atitle><jtitle>Drugs & aging</jtitle><stitle>Drugs Aging</stitle><addtitle>Drugs Aging</addtitle><date>2008-01-01</date><risdate>2008</risdate><volume>25</volume><issue>11</issue><spage>933</spage><epage>946</epage><pages>933-946</pages><issn>1170-229X</issn><eissn>1179-1969</eissn><abstract>Background:
In France, there is evidence to suggest that 50% of elderly individuals are prescribed psychotropic medications. However, it is known that use of these agents increases the risk of falls, fractures and delirium in older people.
Objective:
To study the consumption of ‘potentially inappropriate medication’ (PIM) among patients aged ≥75 years, paying particular attention to psychotropic drugs and the factors influencing the use of ‘potentially inappropriate psychotropics’ (PIPs).
Method:
This was a cross-sectional analysis of a prospective multicentre cohort of 1306 hospitalized French patients aged ≥75 years (the SAFEs [Sujet Âgé Fragile: Évaluation et suivi (Frail Elderly Subjects: Evaluation and follow-up)] cohort). The present analysis involved the 1176 patients for whom there was information on the usual treatments being taken in the 2 weeks before hospitalization. The drugs were coded according to the Anatomical Therapeutic Chemical classification; the Beers list as updated in 2003 defined which medications were considered PIPs. Standardized geriatric assessment variables were recorded on inclusion in the study. Logistic regression analysis was performed to identify factors linked to use of psychotropics and PIPs.
Results:
The mean number of drugs taken was 5.7 ± 2.9 per patient. Twenty-eight percent of patients took at least one PIM. The number of patients who had taken at least one psychotropic drug in the 2 weeks before hospitalization (mean 1.6 ± 0.9 psychotropics per patient) was 589 (50.1%). More than half of both the 510 patients with a depressive syndrome and the 543 patients affected by dementia were treated with psychotropics. Multivariate analysis showed that prescription of psychotropics was linked to the presence of a dementia syndrome (odds ratio [OR] = 1.4; 95% CI 1.1, 1.9; p = 0.03), the presence of a depressive syndrome (OR = 1.7; 95% CI 1.3, 2.1; p < 0.001), living in an institution (OR = 2.2; 95% CI 1.5, 3.4; p < 0.001), use of more than five drugs (OR = 3.2; 95% CI 2.5, 4.2; p < 0.001) and Charlson’s co-morbidity score >1 (OR = 0.6; 95% CI 0.5, 0.8; p = 0.001). Nineteen percent of all psychotropics prescribed were PIPs. Of these PIPs, 66.5% were anxiolytics, 28.4% were antidepressants and 5.1% were antipsychotics. Use of PIPs in the multivariate analysis was associated only with consumption of more than five drugs (OR = 1.7; 95% CI 1.1, 2.5; p = 0.01).
Conclusion:
PIM use is common among hospitalized older adults in France. The most important determinant of risk of receiving a psychotropic medication or a PIP was the number of drugs being taken. The elderly, who have multiple comorbidities, complex chronic conditions and are usually receiving polypharmacy, are at increased risk for adverse drug events. These adverse events are often linked to problems that could be preventable such as delirium, depression and falls. Regular review of prescriptions would help optimize prescription of psychotropics in the elderly. The Beers list is a good tool for evaluating PIMs but is too restrictive with respect to psychotropics; in the latter respect, the list could usefully be widened.</abstract><cop>Cham</cop><pub>Springer International Publishing</pub><pmid>18947261</pmid><doi>10.2165/0002512-200825110-00004</doi><tpages>14</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1170-229X |
ispartof | Drugs & aging, 2008-01, Vol.25 (11), p.933-946 |
issn | 1170-229X 1179-1969 |
language | eng |
recordid | cdi_proquest_journals_223084924 |
source | Springer Link |
subjects | Activities of Daily Living Age Factors Aged - statistics & numerical data Aged patients Aged, 80 and over Biological and medical sciences Cross-Sectional Studies Data Collection Delirium Delirium - complications Delirium - psychology Dementia Dementia - complications Dementia - psychology Dosage and administration Drug Interactions Drug therapy Drug Utilization Emergency medical care Female Frail Elderly - statistics & numerical data Frailty France - epidemiology Geriatrics Geriatrics/Gerontology Health aspects Hospital patients Hospitalization Hospitals Humans Internal Medicine Logistic Models Male Medical sciences Medicine Medicine & Public Health Multivariate analysis Neuropharmacology Older people Original Research Article Patients Pharmacology. Drug treatments Pharmacology/Toxicology Pharmacotherapy Polypharmacy Prescription drugs Prescriptions - standards Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer..., (alzheimer disease) Psychology. Psychoanalysis. Psychiatry Psychopharmacology Psychotropic drugs Psychotropic Drugs - therapeutic use Socioeconomic Factors |
title | Potentially Inappropriate Use of Psychotropic Medications in Hospitalized Elderly Patients in France: Cross-Sectional Analysis of the Prospective, Multicentre SAFEs Cohort |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-19T20%3A47%3A15IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Potentially%20Inappropriate%20Use%20of%20Psychotropic%20Medications%20in%20Hospitalized%20Elderly%20Patients%20in%20France:%20Cross-Sectional%20Analysis%20of%20the%20Prospective,%20Multicentre%20SAFEs%20Cohort&rft.jtitle=Drugs%20&%20aging&rft.au=Prudent,%20Max&rft.date=2008-01-01&rft.volume=25&rft.issue=11&rft.spage=933&rft.epage=946&rft.pages=933-946&rft.issn=1170-229X&rft.eissn=1179-1969&rft_id=info:doi/10.2165/0002512-200825110-00004&rft_dat=%3Cgale_proqu%3EA200671326%3C/gale_proqu%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c430t-9c4e373a2fe6e40a11d4fe9d6c73e5b258872f1c2937fa267669ccd2ad2a079a3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=223084924&rft_id=info:pmid/18947261&rft_galeid=A200671326&rfr_iscdi=true |